.M.E: Project Full Runner will be a useful thing in the future here is it's information.
Chapter 25: Project Full Runner.
The document details Test 001-9 conducted on Subject 2380, Ron Groves, as part of Project Full Runner. The subject was injected with a mutated virus, referred to as The Groves virus or Caput-57, to observe its effects. Ron Groves was born on September 20, 1920, in London, United Kingdom. His father, Bert Groves, was missing, and his mother, Rachel Stevens, was deceased.
Key observations and events during the test:
1. **Appearance of Subject:** The virus caused Ron Groves' skin to turn green, and multiple heads grew on his body. Despite these changes, there were no signs of deteriorating health.
2. **Attempted Reversal:** Researchers attempted to reverse the effects of the virus using an anti-virus. However, the anti-virus failed, leading to the decision to create a specialized antidote named ASJ-99.
- **ASJ-99 Testing:** ASJ-99 was tested but proved ineffective in reversing the virus's effects.
3. **Subject's Mental State:** Ron Groves began muttering phrases such as 'suffering,' 'let it end,' 'pain,' and 'help me, please.' Painkillers were administered to alleviate his distress.
- **Language Variation:** Different heads on his body started speaking different languages, including Old Latin, Mandarin, and German. Translators were requested to assist in communication.
- **Psychotic Behavior:** Ron Groves exhibited psychotic behavior, banging his head against the glass of the holding chamber.
4. **New Antidote (ASJ-100):** A new antidote, ASJ-100, was developed and tested. However, it led to adverse effects, turning the subject's skin light orange, inducing vomiting of a purple substance, and worsening his mental state.
- **Termination Request:** Due to the deteriorating condition of the subject, a request was made to terminate Ron Groves.
5. **Subject's Final Moments:** Ron Groves was terminated via mustard gas inhalation on July 11, 1957, at 16:52 PM. His last words expressed anger and a desire for revenge against the scientists involved in the experiment.
Further testing of The Groves virus and related antidotes (ASJ-99 and ASJ-100) was terminated, and the virus was stored in containment. The antidotes were exterminated.
The document provides a chilling glimpse into the consequences of experimental virology and the ethical challenges faced by scientists involved in such projects.
The document outlines Test 001-13 as part of Project Full Runner, focusing on Subject 2398, Peter Hopson. The Groves virus C-58 (Groves-Moss Disease) was injected into the subject to observe reactions and explore potential cures for both C-58 and its predecessor, C-57.
Key observations and events during the test:
1. **Subject Details:**
- **Full Name:** Peter Hopson
- **Date of Birth:** January 14, 1934
- **Place of Birth:** Huddersfield, UK
- **Father:** Daniel Hopson (Deceased)
- **Mother:** Jasmin Cross (Deceased)
2. **Introduction of C-58:**
- C-58 (Grover-Moss Disease) was introduced as a newer version of the Groves virus after the failure of C-57.
- Unlike C-57, which caused the skin to turn green and multiple heads to grow, C-58 only turned the subject's skin green.
- C-57 was terminated, and all samples of C-57 were exterminated.
3. **Cure Development:**
- A blood sample was taken from Subject 2398 to develop a cure for C-58.
- A possible cure named ASJ-112 was created and tested.
- **Test Results (ASJ-112):**
- Subject 2398 passed away on March 15, 1960.
- ASJ-112 did not have the desired curative effect. Instead, it mutated into a form of Leukopenia.
- The mutated ASJ-112 was rebranded as Moss-Hopson Cell Disease or MHCD-60.
4. **Project "Dying House":**
- Project "Dying House" was initiated to research the new disease, MHCD-60.
5. **Termination and Storage:**
- Subject 2398's death marked the termination of further testing on him.
- C-57 was officially terminated, while C-58 and MHCD-60 were stored for further research.
The document provides insights into the ongoing experimentation with viruses, attempting to understand their effects and find potential cures. However, it also highlights the unintended consequences, such as the creation of new diseases, leading to the initiation of further research projects like "Dying House." Ethical concerns surrounding these experiments are evident in the severe impact on the subjects involved.
The document details Test 001-20LK, part of Project Full Runner, involving Subject 4056 (Alexander Weaver). The project's focus shifted towards weaponizing the Groves virus, C-58, and developing a cure (CU-01) to safeguard against its potential misuse. The test spanned from January 12, 1962, to September 18, 1964.
Key observations and events during the test:
1. **Introduction of C-58 and Vaccine Development:**
- C-58, a virus similar to the common cold, was created from a sample of the Groves virus.
- A vaccine named ASJ-130 was developed to immunize soldiers against C-58.
2. **Testing on Subject 4056 (Alexander Weaver):**
- Subject 4056 received the ASJ-130 vaccine.
- No major symptoms were observed initially.
3. **Onset of Symptoms and Skin Infection:**
- Weeks after vaccination, the subject experienced skin irritation and rashes on the face.
- Further examination revealed that C-58 caused skin irritation leading to infection.
4. **Visual System and Optic Nerve Impact:**
- The virus attacked the visual system, particularly the optic nerve.
- Subject reported itching eyes and eventually black spots in the right eye.
5. **Loss of Vision and Surgical Intervention:**
- Subject lost vision in the right eye.
- Surgery was performed to remove the affected eye, and the optic and ophthalmic nerves were severely damaged.
6. **Cure Development (CU-01):**
- ASJ-130 was deemed ineffective, leading to the development of a cure, CU-01.
- CU-01 was injected into the subject, resulting in positive outcomes.
7. **Recovery and CU-01 Success:**
- Subject showed signs of recovery.
- CU-01 effectively eliminated symptoms, and the subject was released from containment.
8. **Agreement and Public Release:**
- Subject Alexander Weaver was released back into the public.
- Weaver signed an agreement not to disclose information about the test, facing arrest for treason and execution if violated.
9. **Rebranding and Weaponization:**
- C-58 was rebranded as a skin and eye disease, not a mutation disease.
- Symptoms included skin irritation, itching eyes, blindness, skin infection, and skin rashes.
- C-58 was considered a potential biological weapon for use against enemy states.
10. **Project Full Runner Summary:**
- C-57 was terminated in 1960.
- C-58 and MHCD-60 (Moss-Hopson Cell Disease) were born as mutations of C-57.
- C-58 could be cured with CU-01, and MHCD-60 was still under testing.
- ASJ-99 to ASJ-130 were terminated.
The document concludes with the declaration that C-58 is not a threat to public safety, and NATO has contractual control over its potential use against enemy states. The results were written by Dr. David W. Moss on September 20, 1964.